Opposition in India to patent extension for Janssen’s TB drug The Pharma Letter
Two tuberculosis survivors have opposed a patent application filed in India by Janssen Pharmaceutica, which they say could block generic versions of …
Opposition in India to patent extension for Janssen’s TB drug The Pharma Letter
Two tuberculosis survivors have opposed a patent application filed in India by Janssen Pharmaceutica, which they say could block generic versions of …